Literature DB >> 21193543

Genes involved in initial follicle recruitment may be associated with age at menopause.

Marlies Voorhuis1, Frank J Broekmans, Bart C J M Fauser, N Charlotte Onland-Moret, Yvonne T van der Schouw.   

Abstract

CONTEXT: Timing of menopause is largely influenced by genetic factors. Because menopause occurs when the follicle pool in the ovaries has become exhausted, genes involved in primordial follicle recruitment can be considered as candidate genes for timing of menopause.
OBJECTIVE: The aim was to study the association of 23 tagging single nucleotide polymorphisms in five genes [Anti-Müllerian hormone (AMH), AMH type II receptor (AMHR2), bone morphogenetic protein 15 (BMP15), forkhead transcription factor L2 (FOXL2), and growth differentiation factor-9 (GDF9)] involved in recruitment of the primary follicle pool, including the AMHR2 gene, which has recently been associated with age at menopause.
DESIGN: We conducted a cross-sectional association study. SETTING AND PARTICIPANTS: We studied a population-based sample of 3616 Dutch women with natural menopause. MAIN OUTCOME MEASURE: We measured age at natural menopause.
RESULTS: Both studied AMHR2 tagging single nucleotide polymorphisms (rs2002555 and rs11170547) in the AMHR2 gene were associated with age at natural menopause in interaction with parity. Parous rs2002555 G/G carriers had menopause 1 yr later compared with A/A carriers (P = 0.01). For rs11170547, each minor allele (T) was associated with a 0.41-yr later onset of menopause in parous women (P = 0.01). Additionally, rs6521896 in BMP15 was associated with later menopause (β = 0.41; P = 0.007). Variants in the AMH, FOXL2, and GDF9 genes were not associated with timing of menopause.
CONCLUSIONS: The present study confirms an earlier finding that variation in the AMHR2 gene modifies the relation between parity and age at natural menopause. In combination with the association of BMP15 with menopausal age, we find that there is evidence that genes involved in primary follicle recruitment influence timing of menopause.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193543     DOI: 10.1210/jc.2010-1799

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Association of AMH and AMHR2 gene polymorphisms with ovarian response and pregnancy outcomes in Indian women.

Authors:  Stacy Colaco; Swati Achrekar; Akshata Patil; Unnati Sawant; Sadhna Desai; Vijay Mangoli; Padma Rekha Jirge; Deepak Modi; Smita D Mahale
Journal:  J Assist Reprod Genet       Date:  2022-06-17       Impact factor: 3.357

2.  Hypoestrogenic "inactive phases" at the start of the menstrual cycle: changes with age and reproductive stage, and relationship to follicular depletion.

Authors:  Rebecca J Ferrell; Germán Rodríguez; Darryl Holman; Kathleen O'Connor; James W Wood; Maxine Weinstein
Journal:  Fertil Steril       Date:  2012-08-14       Impact factor: 7.329

3.  Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.

Authors:  Neoklis A Georgopoulos; Eleni Karagiannidou; Vasiliki Koika; Nikolaos D Roupas; Anastasia Armeni; Dimitra Marioli; Efstathios Papadakis; C K Welt; Dimitrios Panidis
Journal:  J Clin Endocrinol Metab       Date:  2013-08-22       Impact factor: 5.958

Review 4.  Genomic markers of ovarian reserve.

Authors:  Michelle A Wood; Aleksandar Rajkovic
Journal:  Semin Reprod Med       Date:  2013-10-07       Impact factor: 1.303

5.  Genetic variants in anti-Müllerian hormone-related genes and breast cancer risk: results from the AMBER consortium.

Authors:  Hazel B Nichols; Mariaelisa Graff; Jeannette T Bensen; Kathryn L Lunetta; Katie M O'Brien; Melissa A Troester; Lindsay A Williams; Kristin Young; Chi-Chen Hong; Song Yao; Christopher A Haiman; Edward A Ruiz-Narváez; Christine B Ambrosone; Julie R Palmer; Andrew F Olshan
Journal:  Breast Cancer Res Treat       Date:  2020-09-22       Impact factor: 4.872

6.  Interactions between genetic variants in AMH and AMHR2 may modify age at natural menopause.

Authors:  Marieke G M Braem; Marlies Voorhuis; Yvonne T van der Schouw; Petra H M Peeters; Leo J Schouten; Marinus J C Eijkemans; Frank J Broekmans; N Charlotte Onland-Moret
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

7.  A method to find longevity-selected positions in the mammalian proteome.

Authors:  Jeremy Semeiks; Nick V Grishin
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

8.  Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm.

Authors:  Norbert Gleicher; Vitaly A Kushnir; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2015-04-18       Impact factor: 5.211

9.  Genetic variation and reproductive timing: African American women from the Population Architecture using Genomics and Epidemiology (PAGE) Study.

Authors:  Kylee L Spencer; Jennifer Malinowski; Cara L Carty; Nora Franceschini; Lindsay Fernández-Rhodes; Alicia Young; Iona Cheng; Marylyn D Ritchie; Christopher A Haiman; Lynne Wilkens; Tara C Matise; Christopher S Carlson; Kathleen Brennan; Amy Park; Aleksandar Rajkovic; Lucia A Hindorff; Steven Buyske; Dana C Crawford
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

10.  AMH type II receptor and AMH gene polymorphisms are not associated with ovarian reserve, response, or outcomes in ovarian stimulation.

Authors:  Christian Cerra; William G Newman; Dalia Tohlob; Helen Byers; Gregory Horne; Stephen A Roberts; Lamiya Mohiyiddeen
Journal:  J Assist Reprod Genet       Date:  2016-05-03       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.